BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22162305)

  • 1. Novel cell-penetrating peptides based on α-aminoxy acids.
    Ma Y; Yang D; Ma Y; Zhang YH
    Chembiochem; 2012 Jan; 13(1):73-9. PubMed ID: 22162305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
    Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
    J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
    Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-aminoxy acids: new possibilities from foldamers to anion receptors and channels.
    Li X; Wu YD; Yang D
    Acc Chem Res; 2008 Oct; 41(10):1428-38. PubMed ID: 18785763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
    Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
    Jones S; Howl J
    Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An l- to d-Amino Acid Conversion in an Endosomolytic Analog of the Cell-penetrating Peptide TAT Influences Proteolytic Stability, Endocytic Uptake, and Endosomal Escape.
    Najjar K; Erazo-Oliveras A; Brock DJ; Wang TY; Pellois JP
    J Biol Chem; 2017 Jan; 292(3):847-861. PubMed ID: 27923812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.
    Verdurmen WP; Bovee-Geurts PH; Wadhwani P; Ulrich AS; Hällbrink M; van Kuppevelt TH; Brock R
    Chem Biol; 2011 Aug; 18(8):1000-10. PubMed ID: 21867915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of six-membered carbocyclic ring α,α-disubstituted amino acids and arginine-rich peptides to investigate the effect of ring size on the properties of the peptide.
    Kato T; Kita Y; Iwanari K; Asano A; Oba M; Tanaka M; Doi M
    Bioorg Med Chem; 2021 May; 38():116111. PubMed ID: 33838611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake of Aib-containing amphipathic helix peptide.
    Wada S; Tsuda H; Okada T; Urata H
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5688-91. PubMed ID: 21875799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acylation of octaarginine: Implication to the use of intracellular delivery vectors.
    Katayama S; Hirose H; Takayama K; Nakase I; Futaki S
    J Control Release; 2011 Jan; 149(1):29-35. PubMed ID: 20144669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating proline-rich peptidomimetics.
    Farrera-Sinfreu J; Giralt E; Royo M; Albericio F
    Methods Mol Biol; 2007; 386():241-67. PubMed ID: 18604949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.
    Kamide K; Nakakubo H; Uno S; Fukamizu A
    Int J Mol Med; 2010 Jan; 25(1):41-51. PubMed ID: 19956900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
    Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
    Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E).
    Martín I; Teixidó M; Giralt E
    Chembiochem; 2011 Apr; 12(6):896-903. PubMed ID: 21365733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells.
    Rádis-Baptista G; de la Torre BG; Andreu D
    Chem Biol Drug Des; 2012 Jun; 79(6):907-15. PubMed ID: 22405142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
    Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
    J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.